AlphavAx.com
About AlphavAx.com
AlphaVax is developing a novel vaccine technology with broad applications against infectious disease, cancer and biodefense threats which has the potential to redefine vaccines and the role they play in medicine. The vaccine market is primed for dramatic growth, and the AlphaVax vaccine technology will play a key role in an expanding industry expected to reach $20 billion by 2015.
